CA Stock MarketDetailed Quotes
BHSC BioHarvest Sciences Inc
- 7.600
- -0.200-2.56%
15min DelayMarket Closed Sep 13 15:58 ET
131.69MMarket Cap-4408P/E (TTM)
7.600High7.540Low10.93KVolume7.600Open7.800Pre Close82.94KTurnover10.50052wk High0.09%Turnover Ratio17.33MShares5.60052wk Low-1.724EPS TTM95.51MFloat Cap24.850Historical HighLossP/E (Static)12.57MShs Float1.925Historical Low-1.392EPS LYR0.77%Amplitude--Dividend TTM14.48P/B1Lot Size--Div YieldTTM
BioHarvest Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 66.71%-958K | 4.65%-1.58M | 7.78%-8.52M | -19.57%-2.99M | 60.17%-995K | -65.78%-2.88M | 33.88%-1.66M | -36.02%-9.24M | -9.54%-2.5M | -74.81%-2.5M |
| Net income from continuing operations | 75.89%-687K | -775.13%-6.58M | -11.82%-12.56M | -157.84%-7.24M | 55.99%-1.73M | -19.95%-2.85M | 64.69%-752K | -14.34%-11.24M | -60.07%-2.81M | -28.91%-3.92M |
| Operating gains losses | -543.65%-1.17M | 368.20%5.03M | 493.87%1.55M | 4,314.44%3.97M | -145.94%-368K | -1,106.67%-181K | -204.72%-1.87M | -66.28%261K | -77.16%90K | 265.75%801K |
| Depreciation and amortization | 70.81%357K | 2.02%202K | 17.98%840K | 12.50%216K | 11.86%217K | 10.00%209K | 45.59%198K | 83.03%712K | 39.13%192K | 67.24%194K |
| Remuneration paid in stock | 3.17%195K | 7.26%133K | -58.36%563K | -61.74%132K | -65.19%118K | -3.08%189K | -73.78%124K | -59.85%1.35M | -61.37%345K | -55.16%339K |
| Other non cashItems | -83.56%12K | 116.00%162K | 627.73%866K | 634.58%572K | -43.85%146K | 170.19%73K | 7.14%75K | 109.41%119K | 94.18%-107K | 12.07%260K |
| Change In working capital | 219.44%344K | -182.12%-496K | 345.13%755K | 13.58%-299K | 2,738.46%738K | -170.24%-288K | 251.76%604K | -220.83%-308K | -349.35%-346K | -92.12%26K |
| -Change in receivables | -141.94%-75K | -239.22%-213K | 96.26%-22K | 61.48%-141K | 92.31%-3K | 41.51%-31K | 217.69%153K | -121.05%-588K | -832.00%-366K | 57.61%-39K |
| -Change in inventory | 180.00%108K | 56.25%-210K | -141.78%-1.09M | -483.33%-391K | -485.71%-82K | 41.56%-135K | -56.35%-480K | 45.65%-450K | 130.27%102K | 91.30%-14K |
| -Change in payables and accrued expense | 354.92%311K | -107.84%-73K | 155.48%1.87M | 384.15%233K | 941.77%823K | -117.58%-122K | 2,287.18%931K | -26.85%730K | -139.05%-82K | -86.45%79K |
| Interest paid (cash flow from operating activities) | 53.33%-14K | 20.00%-24K | -277.30%-532K | -375.78%-353K | 38.66%-119K | 16.67%-30K | 23.08%-30K | -3.68%-141K | 412.20%128K | -410.53%-194K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 66.71%-958K | 4.65%-1.58M | 7.78%-8.52M | -19.57%-2.99M | 60.17%-995K | -65.78%-2.88M | 33.88%-1.66M | -36.02%-9.24M | -9.54%-2.5M | -74.81%-2.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -426.70%-1.93M | 40.96%-222K | -17.36%-1.47M | -10.65%-291K | -57.71%-440K | -13.62%-367K | 3.84%-376K | 23.41%-1.26M | 25.71%-263K | 44.86%-279K |
| Net PPE purchase and sale | -365.40%-1.71M | 40.96%-222K | -17.36%-1.47M | -10.65%-291K | -57.71%-440K | -13.62%-367K | 3.84%-376K | 23.41%-1.26M | 25.71%-263K | 44.86%-279K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -426.70%-1.93M | 40.96%-222K | -17.36%-1.47M | -10.65%-291K | -57.71%-440K | -13.62%-367K | 3.84%-376K | 23.41%-1.26M | 25.71%-263K | 44.86%-279K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -2.97%4.61M | -118.80%-116K | 66.58%13.56M | 214.16%7.01M | -69.15%1.18M | 133.96%4.75M | 1,334.88%617K | -24.45%8.14M | 4,309.43%2.23M | -26.85%3.84M |
| Net issuance payments of debt | -102.74%-119K | -120.91%-129K | 80.20%13.15M | 209.04%7.01M | -61.90%1.18M | 114.10%4.34M | 699.03%617K | 2,298.49%7.3M | 2,301.94%2.27M | 3,475.00%3.11M |
| Proceeds from stock option exercised by employees | 1,072.46%4.73M | --13K | -54.05%403K | --0 | --0 | --403K | --0 | -75.89%877K | --1K | -72.26%730K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---38K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -2.97%4.61M | -118.80%-116K | 66.58%13.56M | 214.16%7.01M | -69.15%1.18M | 133.96%4.75M | 1,334.88%617K | -24.45%8.14M | 4,309.43%2.23M | -26.85%3.84M |
| Net cash flow | ||||||||||
| Beginning cash position | 1,045.33%3.44M | 208.47%5.36M | -57.83%1.74M | -31.38%1.56M | 49.26%1.81M | -76.30%300K | -57.83%1.74M | 130.90%4.12M | -66.65%2.27M | -65.36%1.21M |
| Current changes in cash | 14.18%1.72M | -35.50%-1.92M | 250.91%3.56M | 794.78%3.72M | -123.82%-252K | 5,106.67%1.5M | 50.40%-1.41M | -200.90%-2.36M | 80.10%-536K | -68.02%1.06M |
| Effect of exchange rate changes | 70.00%17K | 86.36%-3K | 368.18%59K | --72K | ---1K | 145.45%10K | ---22K | -450.00%-22K | --0 | --0 |
| End cash Position | 185.21%5.17M | 1,045.33%3.44M | 208.47%5.36M | 208.47%5.36M | -31.38%1.56M | 49.26%1.81M | -76.30%300K | -57.83%1.74M | -57.83%1.74M | -66.65%2.27M |
| Free cash from | 17.84%-2.67M | 11.37%-1.8M | 4.77%-10M | -18.72%-3.29M | 48.33%-1.44M | -57.60%-3.25M | 29.82%-2.03M | -24.46%-10.5M | -4.81%-2.77M | -43.51%-2.78M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data